Investigational Site Number :6430010

Saint Petersburg 199034

0 studies enrolling now · 4 studies all time

What they study most

Asthma, Breast Cancer, Chronic Obstructive Pulmonary Disease, Type 2 Diabetes Mellitus

Studies at this site

• Amcenestrant (SAR439859) Plus Palbociclib as First Line Therapy for Patients With ER (+) HER2(-) Advanced Breast Cancer — Stopped early
• Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of SAR440340 (Anti-IL-33 mAb) in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) — Completed
• Evaluation of SAR440340 and as Combination Therapy With Dupilumab in Moderate-to-Severe Asthma Participants — Completed
• Effect of Efpeglenatide on Cardiovascular Outcomes — Stopped early